Recent patents in dengue disease management

Area of Science:

• * Virology and Infectious Diseases
• * Public Health and Epidemiology
• * Patent Law and Intellectual Property

Background:

• * Dengue fever, caused by four serotypes of the dengue virus, is a significant global health concern, particularly in Asia and Latin America.
• * The disease presents a spectrum of illness, from asymptomatic infections to severe, life-threatening conditions, with increasing prevalence in endemic and newly affected regions.
• * Current control measures are insufficient, and despite ongoing efforts, there is no approved dengue vaccine or potent antiviral drug available.

Purpose of the Study:

• * To review and analyze recent patents focused on novel strategies for dengue virus control.
• * To highlight innovative approaches in vaccine development and antiviral therapies.
• * To provide insights into the patent landscape for dengue therapeutics and prevention.

Main Methods:

• * Comprehensive search and analysis of patent databases for recent filings related to dengue control.
• * Categorization of patents based on therapeutic approach (e.g., vaccines, antivirals) and target (e.g., specific viral proteins, host factors).
• * Review of patent claims and descriptions to identify novel mechanisms and technologies.

Main Results:

• * Identification of a growing number of patents detailing innovative dengue vaccine candidates, including those targeting different viral serotypes.
• * Emergence of patents for novel antiviral compounds and drug delivery systems aimed at inhibiting dengue virus replication.
• * Patents also cover vector control strategies and diagnostic tools, reflecting a multi-pronged approach to dengue management.

Conclusions:

• * The patent landscape indicates significant ongoing innovation in the development of new dengue control measures.
• * Recent patents demonstrate promising advancements in both preventative (vaccines) and therapeutic (antivirals) strategies.
• * Continued research and development, supported by intellectual property, are crucial for addressing the global burden of dengue fever.